Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
OTC Drugs

NACDS Foundation officers

This article was originally published in The Tan Sheet

  • News

Executive Summary

The National Association of Chain Drug Stores Foundation elects officers at its April 28 annual meeting in Palm Beach, Fla. Five new members were elected to the board of directors, and 18 were re-elected. The new members are Charles Burnett, Costco Wholesale senior VP pharmacy; Lynn Campbell, Coca-Cola's Shopper Marketing director for drug, club, mass and military; Art Drogue, Unilever senior VP for U.S. customer development; Fougera CEO Paul McGarty; and Apotex Corp. President Tammy McIntire. In addition, NACDS executives were re-elected as board officers. They are President and CEO Steven Anderson as chairman, VP External Affairs Phillip Schneider as president, vice VP Pharmacy Education and Research Sandra Guckian as secretary and Executive VP Finance and Administration James Huber as treasurer...

Table

View full table

Topics

Tags:
OTC Drugs
Latest Headlines

Mismatch Between Growing Vaccine Pipeline and CDC’s ACIP Capacity

Keeping Track: Two Breakthrough Oncologics, Another Antibiotic Clear US FDA Along With Pfizer’s Hemophilia B Gene Therapy

Priority Review Vouchers: Tropical Disease Candidates Wait Years For FDA Action On Qualifying List

Pink Sheet Podcast: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics

See All
UsernamePublicRestriction

Register

PS101642

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By